Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
BRKR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$30.00 - $72.94
Previous CloseN/A
Volume340.61K
Average Volume (3M)3.47M
Market Cap
$5.17B
Enterprise Value$8.66B
Total Cash (Recent Filing)$92.00M
Total Debt (Recent Filing)$2.44B
Price to Earnings (P/E)66.1
Beta1.13
Next Earnings
Oct 30, 2025EPS Estimate
0.33Next Dividend Ex-Date
Sep 23, 2025Dividend Yield0.6%
Share Statistics
EPS (TTM)0.32
Shares Outstanding151,719,360
10 Day Avg. Volume2,218,658
30 Day Avg. Volume3,474,212
Financial Highlights & Ratios
PEG Ratio-1.04
Price to Book (P/B)4.90
Price to Sales (P/S)2.59
P/FCF Ratio64.22
Enterprise Value/Market Cap1.68
Enterprise Value/Revenue2.51
Enterprise Value/Gross Profit5.24
Enterprise Value/Ebitda33.92
Forecast
1Y Price Target
$45.91Price Target Upside36.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
Cost Savings InitiativesA $100 million+ cost saving program is expected to bolster operating margins in 2026, helping BRKR to deliver significant margin expansion and earnings growth even with flat revenue.
Potential UpsidePotential upside is seen from China stimulus, which should become more pronounced as the year progresses.
Valuation And Market SentimentThe analyst reiterates a Buy rating, believing the valuation reflects BRKR’s current situation, with potential upside when conditions improve.
Bears Say
Debt And LeverageGross leverage breached 4x at 2Q-end, and management noted that subsequent to 2Q-end, they had borrowed an additional $457M of debt under the credit agreement, which brings calculations closer to 5x.
Demand PressureBRKR continues to face broad-based demand pressure with no near-term relief in sight across academic, government, industrial, and biopharma sectors.
Guidance CutsSteady guide cuts this year starting from 3-4% org growth in Feb to now -2% to -4% decline have driven the stock to its 5-yr low and valuation of ~10.5x EV/EBITDA 2026, as BRKR faces multiple macro headwinds with academic/NIH impact being most significant.
Bruker News
BRKR FAQ
What was Bruker Corp’s price range in the past 12 months?
Bruker Corp lowest stock price was $30.00 and its highest was $72.94 in the past 12 months.
What is Bruker Corp’s market cap?
Bruker Corp’s market cap is $5.17B.
When is Bruker Corp’s upcoming earnings report date?
Bruker Corp’s upcoming earnings report date is Oct 30, 2025 which is in 62 days.
How were Bruker Corp’s earnings last quarter?
Bruker Corp released its earnings results on Aug 04, 2025. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.412 by -$0.092.
Is Bruker Corp overvalued?
According to Wall Street analysts Bruker Corp’s price is currently Undervalued.
Does Bruker Corp pay dividends?
Bruker Corp pays a Quarterly dividend of $0.05 which represents an annual dividend yield of 0.6%. See more information on Bruker Corp dividends here
What is Bruker Corp’s EPS estimate?
Bruker Corp’s EPS estimate is 0.33.
How many shares outstanding does Bruker Corp have?
Bruker Corp has 151,719,360 shares outstanding.
What happened to Bruker Corp’s price movement after its last earnings report?
Bruker Corp reported an EPS of $0.32 in its last earnings report, missing expectations of $0.412. Following the earnings report the stock price went down -8.608%.
Which hedge fund is a major shareholder of Bruker Corp?
Currently, no hedge funds are holding shares in BRKR
Bruker Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$45.91 (36.68% Upside)
$45.91 (36.68% Upside)
Blogger Sentiment
Bullish
BRKR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 243.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.2%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.48%
12-Months-Change
Fundamentals
Return on Equity
4.43%
Trailing 12-Months
Asset Growth
7.41%
Trailing 12-Months
Company Description
Bruker Corp
Bruker Corporation (BRKR) is a global leader in scientific instrumentation and analytical solutions, primarily serving the life sciences, materials science, and industrial markets. The company specializes in the development and production of advanced technologies, including mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, X-ray diffraction, and optical microscopy. With a strong emphasis on innovation, Bruker delivers high-performance instruments and integrated solutions that enable researchers and scientists to gain insights into complex biological and material properties.
BRKR Company Deck
BRKR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted successful product innovations and a strategic cost savings initiative. However, significant revenue declines, EPS reductions, and challenges in key markets such as the U.S. and China, coupled with unfavorable tariff and currency conditions, paint a mixed picture. While the company is optimistic about future growth and margin improvements, current market conditions are challenging.View all BRKR earnings summariesBRKR Stock 12 Month Forecast
Average Price Target
$45.91
▲(36.68% Upside)
Technical Analysis
Bio-Rad Laboratories
―
Integer Holdings
―
LivaNova
―
Xtant Medical Holdings
―
Irhythm Technologies
―
Ownership Overview
26.98% Insiders
23.94% Mutual Funds
32.64% Other Institutional Investors
0.62% Public Companies and Individual Investors